IBCP Independent Bank Corporation

NASDAQ
$36.96

Independent Bank's First Quarter With HCB Tests Loan Momentum and Rising Problem Credits

Independent Bank Corporation enters its third-quarter report with the strongest operating story it has told in a year and a stock that has refused to give it credit. Last quarter brought a burst of loan growth, a twelfth straight increase in net interest income and the long-awaited closing of the HCB Financial acquisition on July 1. Since then the shares have slipped 3.1% while the S&P 500 gained 3.2%. The report due before the open on October 27 is the first to include HCB, which makes it the cleanest early read on whether the momentum management described is real and durable.

The Street is looking for earnings of $0.86 a share, up a modest 2.4% from $0.84 a year ago but below the $0.90 posted last quarter. That step down looks sensible rather than gloomy. Second-quarter results were flattered by non-interest income of $15.3 million, well above the company's own $11.3 million to $12.3 million forecast, helped by mortgage servicing and a gain on Visa shares that should not be expected to repeat. HCB also arrives with its costs intact: the bank is running it as a separate subsidiary until a November 9 systems conversion, and the roughly 40% cost savings are not expected to be fully realized until early 2027. Consensus revenue of $68.1 million implies a 16% year-over-year drop, which is difficult to reconcile with an acquisition and a growing loan book and likely reflects differences in how revenue is measured. Earnings per share is the more meaningful bar.

The central operating question is whether loan growth can stay well above plan. Loans grew at a 9.8% annualized rate in the second quarter, with commercial loans up 16%, far ahead of the full-year outlook of 4.5% to 5.5% and a sharp rebound from roughly 3% in the prior two reported quarters. A growing team of commercial bankers, now 53 after eight hires this year, and two new regional president roles give that story some structural support. Organic growth that remains comfortably above the original outlook, separated from loans acquired with HCB, would validate the more confident tone. A return toward low single digits would suggest the second quarter was lumpy rather than a new trend. The margin is the second pillar. After climbing from 3.54% to 3.71% over four quarters, management pointed to another 2 to 4 basis points of expansion per quarter. Anything in that range, after accounting for acquisition accounting effects, keeps the earnings engine intact.

Credit is the thread that could unravel the narrative. Non-performing loans have climbed every quarter, from 48 basis points to 74 basis points, or $32.8 million. About two-thirds sits in a single, well-reserved commercial development project caught in a legal process with no clear resolution date, and a second commercial credit moved to non-accrual on an operator problem. Another increase concentrated in those known names would be tolerable. New problem loans spreading to other borrowers, or rising collection and litigation costs that keep expenses pinned near the high end, would challenge the idea that the issue is idiosyncratic.

Sentiment has swung from clearly bearish before the last report to mildly bullish now, yet the stock sits near the bottom of its post-earnings range of $34.53 to $39.24, just above its 200-day moving average of $35.20. That combination suggests a market that likes the operating story but remains wary of credit and integration risk. If Independent can show organic loan growth well ahead of plan, a margin still inching higher and non-performing loans contained to familiar names, the gap between fundamentals and the share price becomes hard to justify. If credit deterioration broadens, the stock's skepticism will look well placed.

← Back to IBCP news